Enzolytics, Inc. (OTCPK: ENZC)
Health Care · Biotechnology · US
$0.00
+25.00% today · +100.0% 1Y
Enzolytics, Inc. (OTCPK: ENZC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.42M and employs 1 people.
Over the last twelve months the share price has gained 100.0%, trading between 0.00 and 0.00.
Tweenvest scores Enzolytics, Inc. across four factors: quality 13/100, value 58/100. Its strongest factor is value.
ENZC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.42M
- Revenue (TTM)
- $46.59K
- P/E
- —
- EPS
- -4.76
- Dividend yield
- —
- Beta (5Y)
- 0.74
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.83B
- Employees
- 1
- Next earnings
- —
About Enzolytics, Inc.
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The company possesses patented anti-HIV treatments that have successfully completed clinical testing. Additionally, Enzolytics has developed a unique methodology for manufacturing human IgG1 monoclonal antibodies, intended to provide non-toxic passive immunotherapy against various infectious diseases. A significant achievement includes the creation of a proprietary cell line, specifically engineered to produce human monoclonal antibodies that effectively target and neutralize the human immunodeficiency virus (HIV).
- ISIN
- US2941121079
- Listed since
- Apr 8, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Spermosens AB (publ)NGM: SPERM | $2.67M | Skr0.01 | -2.33% |
| ExpreS2ion Biotech Holding AB (publ)OM: EXPRS2 | $2.59M | Skr1.04 | -5.02% |
| Matinas BioPharma Holdings, Inc.NYSEAM: MTNB | $2.59M | $2.80 | +6.06% |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $2.58M | $0.40 | -39.82% |
| CASI Pharmaceuticals, Inc.OTCPK: CASI.F | $2.41M | $0.12 | -9.16% |
| ValiRx plcAIM: VAL | $2.36M | £0.00 | +8.00% |
| International Stem Cell CorporationOTCPK: ISCO | $2.32M | $0.29 | -16.08% |
| Oncology Pharma Inc.OTCPK: ONPH | $2.32M | $0.06 | +50.00% |
Figures last refreshed Oct 4, 2026.